Literature DB >> 21359546

What is expected from the pathologist in the diagnosis of viral hepatitis?

Helmut Denk1.   

Abstract

The clinician expects from the pathologist a clinically relevant diagnosis on the basis of liver biopsy interpretation. Today, a liver biopsy, as invasive procedure, is only justified when a significant benefit for the patient can be expected particularly with respect to the clinical management. Consequently, liver biopsy is usually not required in uncomplicated acute viral hepatitis. It is, however, an important diagnostic tool in chronic hepatitis and in transplanted liver to confirm the clinical diagnosis and to assess stage and grade of necroinflammation, treatment efficiency, and concurrent diseases. The diagnosis of liver disease is based on teamwork between clinician and pathologist. Evaluation of the biopsy in the clinical context requires clinical information and appropriate size and handling of the biopsy specimen. Aim of this review is the discussion of morphologic features of acute and chronic viral hepatitis with regard to their clinical relevance.

Entities:  

Mesh:

Year:  2011        PMID: 21359546     DOI: 10.1007/s00428-011-1057-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  102 in total

1.  Liver biopsy size matters in chronic hepatitis: bigger is better.

Authors:  Peter J Scheuer
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

Review 2.  Molecular diagnostic approach to liver tissue as an ancillary tool for liver histopathology.

Authors:  Louis Libbrecht; Tania Roskams
Journal:  Semin Liver Dis       Date:  2006-11       Impact factor: 6.115

3.  CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.

Authors:  Daniel Seehofer; Nada Rayes; Stefan G Tullius; Christian A Schmidt; Ulf P Neumann; Cornelia Radke; Utz Settmacher; Andrea R Müller; Thomas Steinmüller; Peter Neuhaus
Journal:  Liver Transpl       Date:  2002-12       Impact factor: 5.799

4.  Novel type of hepatitis B virus mutation: replacement mutation involving a hepatocyte nuclear factor 1 binding site tandem repeat in chronic hepatitis B virus genotype E.

Authors:  Kei Fujiwara; Yasuhito Tanaka; Emma Paulon; Etsuro Orito; Masaya Sugiyama; Kiyoaki Ito; Ryuzo Ueda; Masashi Mizokami; Nikolai V Naoumov
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  [Liver biopsy in chronic hepatitis C. Histopathology, molecular diagnostic analysis, and implications for therapeutic management].

Authors:  V Dries; M Odenthal; P Schirmacher; H P Dienes
Journal:  Pathologe       Date:  2001-11       Impact factor: 1.011

6.  Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.

Authors:  Laetitia Fartoux; Olivier Chazouillères; Dominique Wendum; Raoul Poupon; Lawrence Serfaty
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

Review 7.  Hepatitis E and pregnancy: understanding the pathogenesis.

Authors:  Udayakumar Navaneethan; Mayar Al Mohajer; Mohamed T Shata
Journal:  Liver Int       Date:  2008-07-25       Impact factor: 5.828

Review 8.  HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?

Authors:  J T Blackard; K E Sherman
Journal:  J Viral Hepat       Date:  2008-01-17       Impact factor: 3.728

9.  Recurrent hepatitis B in liver allografts: a distinctive form of rapidly developing cirrhosis.

Authors:  R F Harrison; M H Davies; R D Goldin; S G Hubscher
Journal:  Histopathology       Date:  1993-07       Impact factor: 5.087

10.  Evolution of hepatitis C virus in liver allografts.

Authors:  Anthony J Demetris
Journal:  Liver Transpl       Date:  2009-11       Impact factor: 5.799

View more
  1 in total

1.  Histological Patterns of Hepatitis and Cholangitis.

Authors:  Raouf E Nakhleh
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-05-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.